Condensations of single DNA molecules induced by heptaplatin and its chiral isomer
Source abstract
Abstract
Heptaplatin is a third-generation platinum antitumor drug. It has a chiral isomer. We studied the interactions between the two isomers and DNA by using magnetic tweezers and atomic force microscopy (AFM) to investigate the effect of chiralities of the isomers on the interactions. We found that the extension curves and average condensation rates of DNA molecules incubated with heptaplatin were nearly the same as those incubated with its chiral isomer. In addition, the structures of DNA molecules incubated with heptaplatin were also similar to those incubated with its chiral isomer. These results indicate the difference in chirality of the two isomers does not induce different interactions of the isomers with DNA. Our study may facilitate the understanding of interactions of platinum complexes with DNA and the design of new antitumor platinum complexes.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Metal complexes synthesis and properties · DNA and Nucleic Acid Chemistry · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chinese Academy of Sciences Key Laboratory of Soft Matter Physics, Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, , Beijing 100190, China
Funding
National Natural Science Foundation of China
References (31)
Show source-provided references
1. Mol. Pharmacol. · 2000 · 58 · 92010.1124/mol.58.5.920 ↗
2. Chem. Rev. · 1999 · 99 · 246710.1021/cr980421n ↗
3. Nucleic Acids Res. · 2009 · 37 · 140010.1093/nar/gkn933 ↗
4. Phys. Rev. E · 2012 · 85 · 02191810.1103/PhysRevE.85.021918 ↗
5. Phys. Rev. Lett. · 2008 · 101 · 24810110.1103/PhysRevLett.101.248101 ↗
6. Phys. Rev. E · 2013 · 88 · 04270310.1103/PhysRevE.88.042703 ↗
7. Nucleic Acids Res. · 1998 · 26 · 147310.1093/nar/26.6.1473 ↗
8. Cancer Res. Treat. · 2009 · 41 · 1210.4143/crt.2009.41.1.12 ↗
9. Cancer · 2001 · 91 · 154910.1002/1097-0142(20010415)91:8<1549::AID-CNCR1164>3.0.CO;2-2 ↗
10. Cancer Chemoth. Pharm. · 2002 · 50 · 10410.1007/s00280-002-0483-x ↗
11. J. Korean Med. Sci. · 2004 · 19 · 36910.3346/jkms.2004.19.3.369 ↗
12. Pharm. Weekblad · 1985 · 7 · 17310.1007/BF02307573 ↗
13. Cell. Mol. Life Sci. · 2002 · 59 · 191410.1007/PL00012514 ↗
14. Metallomics · 2010 · 2 · 1910.1039/b911438f ↗
15. Cancer Res. · 1981 · 41 · 4368
16. J. Cancer Res. Clin. · 1993 · 120 · 12
17. Cancer Lett. · 1995 · 97 · 17710.1016/0304-3835(95)03974-2 ↗
18. J. Med. Chem. · 1987 · 30 · 71610.1021/jm00387a023 ↗
19. Inorg. Chim. Acta · 1987 · 137 · 4510.1016/S0020-1693(00)87114-5 ↗
20. J. Cancer Res. Clin. · 1994 · 120 · 40910.1007/BF01240140 ↗
21. Inorg. Chem. · 1986 · 25 · 110.1021/ic00221a001 ↗
22. Biophys. J. · 2007 · 93 · 395010.1529/biophysj.107.116996 ↗
23. Inorg. Chem. · 1990 · 29 · 449610.1021/ic00347a032 ↗
24. P. Natl. Acad. Sci. USA · 2003 · 100 · 361110.1073/pnas.0737293100 ↗
25. Plos One · 2013 · 8 · e7155610.1371/journal.pone.0071556 ↗
26. J. Mol. Biol. · 2004 · 341 · 125110.1016/j.jmb.2004.06.066 ↗
27. Biochemistry-Us · 1998 · 37 · 923010.1021/bi973176v ↗
28. Nature · 1995 · 377 · 64910.1038/377649a0 ↗
29. Inorg. Chem. · 2001 · 40 · 559610.1021/ic010790t ↗
30. Inorg. Chim. Acta · 1986 · 123 · 22510.1016/S0020-1693(00)85679-0 ↗
31. Inorg. Chim. Acta · 1992 · 198 · 87310.1016/S0020-1693(00)92433-2 ↗